Table 4.
Multivariate regression analysis between BASMIlin and other clinical and demographic variables at year 5a
BASMIlin (dependent variable) |
|||
---|---|---|---|
Parameter estimate (s.e.) | t-value | P-value | |
Intercept | 0.852 (0.47) | 1.82 | 0.07 |
Age, years | 0.046 (0.01) | 3.99 | 0.0001 |
BASFI 0–10 cm VAS | 0.44 (0.06) | 6.75 | <0.0001 |
R2 = 0.44 | |||
Adjusted R2 = 0.43 |
aAnalysis is for the population who completed 5 years of adalimumab treatment. BASMIlin: linear BASMI.